IPP Bureau
Innocan Pharma granted first patent in India for its Liposomal CBD Injection
By IPP Bureau - February 20, 2025
Innovative chronic pain treatment receives IP protection in India's $55 billion pharmaceutical market
IMCD showcases ‘Skinification’ trend at HPCI India 2025
By IPP Bureau - February 19, 2025
IMCD India’s innovative formulations bring the Skinification trend to life with cutting-edge solutions across beauty and personal care
Merck’s Welireg receives European approval for two indications
By IPP Bureau - February 19, 2025
WELIREG is the first and only oral hypoxia-inducible factor-2 alpha inhibitor approved in the European Union
KIMS partners with UAIMS Hospital
By IPP Bureau - February 19, 2025
This strategic partnership will also enable KIMS to exercise call option (not an obligation) to acquire majority stake in UAIMS Hospital in the coming years
Sun Pharma amongst top 5% of global pharmaceutical companies in S&P Global Sustainability Yearbook 2025
By IPP Bureau - February 19, 2025
This Yearbook aims to distinguish those companies that have demonstrated strengths in corporate sustainability
Lupin receives “A-” leadership rating from CDP in climate change and water security
By IPP Bureau - February 19, 2025
This rating reflects Lupin's leadership in environmental transparency and performance
EyeQ upgrades eye care facility in Surat
By IPP Bureau - February 18, 2025
Theatre (OTs) dedicated to cataract, LASIK, and retina treatments added to meet the growing demand
Health Minister inaugurates Second AIIMS Oncology Conclave at NCI-AIIMS, Jhajjar
By IPP Bureau - February 18, 2025
Dr. Prabhavathi. R joins HEJJE
By IPP Bureau - February 18, 2025
Dr. Prabhavathi brings over 14 years of unparalleled experience in pediatrics and a specialized focus on neurodevelopmental disorders
ALPLA opens new manufacturing plant in Thailand
By IPP Bureau - February 17, 2025
ALPLA is going to manufacture high-quality plastic bottles, preforms, matching closures and injection-molded parts in Chachoengsao using all core technologies
Glenmark Pharma reports Q3 FY25 PAT at Rs. 348 Cr
By IPP Bureau - February 17, 2025
Glenmark’s consolidated revenue was at Rs. 3,387.6 crore as against Rs. 2,506.7 crore recording an increase of 35.1% YoY
GSK’s Penmenvy approved by FDA to help protect against MenABCWY
By IPP Bureau - February 17, 2025
Vaccine helps protect against five common disease-causing serogroups of Neisseria meningitidis (A, B, C, W and Y)
Sanofi updates on extraintestinal pathogenic E. coli vaccine phase 3 clinical study
By IPP Bureau - February 17, 2025
No safety signals related to the vaccine candidate were identified
Nectar Life Care launches affordable anti-diabetic range of medicines
By IPP Bureau - February 17, 2025
Offers affordable, high-quality solutions for diabetes care
AbbVie Appoints CEO Robert A. Michael as Chairman of the Board of Directors
By IPP Bureau - February 15, 2025
Richard A. Gonzalez to retire from the board of directors effective July 1, 2025
